Nwam LLC Acquires 243 Shares of The Cigna Group (NYSE:CI)

Nwam LLC raised its holdings in shares of The Cigna Group (NYSE:CIFree Report) by 30.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,044 shares of the health services provider’s stock after acquiring an additional 243 shares during the quarter. Nwam LLC’s holdings in The Cigna Group were worth $293,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in CI. Kalos Management Inc. bought a new position in shares of The Cigna Group in the first quarter valued at approximately $27,000. MBM Wealth Consultants LLC purchased a new stake in The Cigna Group in the 4th quarter worth approximately $36,000. Activest Wealth Management bought a new position in The Cigna Group in the 2nd quarter valued at $34,000. McClarren Financial Advisors Inc. grew its position in shares of The Cigna Group by 672.2% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 139 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 121 shares in the last quarter. Finally, Archer Investment Corp increased its holdings in shares of The Cigna Group by 1,038.5% in the second quarter. Archer Investment Corp now owns 148 shares of the health services provider’s stock worth $42,000 after purchasing an additional 135 shares during the period. Hedge funds and other institutional investors own 85.32% of the company’s stock.

Insider Buying and Selling at The Cigna Group

In other news, EVP Cynthia Ryan sold 3,768 shares of the stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $282.22, for a total transaction of $1,063,404.96. Following the completion of the sale, the executive vice president now directly owns 5,503 shares in the company, valued at $1,553,056.66. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, EVP Cynthia Ryan sold 3,768 shares of the business’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $282.22, for a total transaction of $1,063,404.96. Following the transaction, the executive vice president now directly owns 5,503 shares of the company’s stock, valued at $1,553,056.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Nicole S. Jones sold 7,819 shares of the firm’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $276.86, for a total value of $2,164,768.34. Following the completion of the sale, the executive vice president now directly owns 30,069 shares of the company’s stock, valued at approximately $8,324,903.34. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on CI. Bank of America lifted their price objective on The Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Friday, August 4th. Royal Bank of Canada reissued a “sector perform” rating and set a $327.00 price objective on shares of The Cigna Group in a report on Wednesday. Sanford C. Bernstein raised their target price on shares of The Cigna Group from $326.00 to $330.00 in a research note on Tuesday, October 10th. Raymond James boosted their price target on shares of The Cigna Group from $310.00 to $330.00 and gave the stock a “strong-buy” rating in a research note on Monday, August 7th. Finally, Cantor Fitzgerald raised their price objective on shares of The Cigna Group from $310.00 to $334.00 and gave the company a “neutral” rating in a research report on Friday, November 3rd. Five research analysts have rated the stock with a hold rating, five have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $336.40.

Get Our Latest Analysis on CI

The Cigna Group Stock Up 0.1 %

CI opened at $282.56 on Friday. The Cigna Group has a 12 month low of $240.50 and a 12 month high of $340.11. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.61. The business’s 50-day moving average price is $294.98 and its 200-day moving average price is $281.20. The company has a market cap of $82.68 billion, a P/E ratio of 15.94, a P/E/G ratio of 1.02 and a beta of 0.65.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, November 2nd. The health services provider reported $6.77 EPS for the quarter, topping analysts’ consensus estimates of $6.68 by $0.09. The business had revenue of $49.05 billion for the quarter, compared to analysts’ expectations of $48.14 billion. The Cigna Group had a return on equity of 12.62% and a net margin of 2.79%. The business’s quarterly revenue was up 8.3% on a year-over-year basis. During the same period in the previous year, the firm earned $6.04 EPS. On average, equities analysts expect that The Cigna Group will post 24.82 EPS for the current year.

The Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 21st. Shareholders of record on Wednesday, December 6th will be issued a $1.23 dividend. This represents a $4.92 dividend on an annualized basis and a yield of 1.74%. The ex-dividend date is Tuesday, December 5th. The Cigna Group’s dividend payout ratio (DPR) is presently 27.75%.

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.